FDA Approved: VIGAMOX — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

The FDA approved a supplemental application for VIGAMOX (moxifloxacin hydrochloride) submitted by Harrow Eye, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• VIGAMOX (Moxifloxacin hydrochloride)

Snippet

SUPPL AP for VIGAMOX (MOXIFLOXACIN HYDROCHLORIDE)